The PEGylated Proteins Market is primarily driven by the growing demand for effective drug delivery systems, particularly in the treatment of chronic diseases such as cancer, hepatitis, and rheumatoid ...
GlobalData on MSN17h
Adaptimmune nears second sarcoma approval as Phase II trial hits endpointsAdaptimmune’s Phase II IGNYTE-ESO trial investigating experimental T cell therapy lete-cel has achieved its primary endpoint.
Thermo Fisher Scientific has signed an agreement with Mainz Biomed to develop and launch a next-generation colorectal cancer ...
The global digital PCR market, initially valued at $678.1 million in 2023, is poised for substantial growth, projected to surge to $3.35 billion by 2034, marking a remarkable compound annual growth ...
The global protein expression market is expected to reach USD 4.82 billion in 2029 from USD 3.41 billion in 2024 at a CAGR of ...
Worldwide Healthcare Trust PLC - Half-year Report PR Newswire LONDON, United Kingdom, November 15 LONDON STOCK EXCHANGE ANNOUNCEMENTWorldwide Healthcare Trust PLCUnaudited ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback